FADS6 | Fatty acid desaturase 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM3B | Family with sequence similarity 3, member B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM83E | Family with sequence similarity 83, member E | Predicted intracellular proteins
| | | | | Tissue enhanced |
FLVCR1 | Feline leukemia virus subgroup C cellular receptor 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GAL3ST1 | Galactose-3-O-sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GATA5 | GATA binding protein 5 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GCNT4 | Glucosaminyl (N-acetyl) transferase 4, core 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
GPR112 | G protein-coupled receptor 112 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR128 | G protein-coupled receptor 128 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR35 | G protein-coupled receptor 35 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GSDMB | Gasdermin B | Predicted intracellular proteins
| | | | | Tissue enhanced |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HKDC1 | Hexokinase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HTR3E | 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KRT12 | Keratin 12 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT8 | Keratin 8 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
LCN15 | Lipocalin 15 | Predicted secreted proteins
| | | | | Tissue enhanced |
LRAT | Lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRRC66 | Leucine rich repeat containing 66 | Predicted membrane proteins
| | | | | Tissue enhanced |
LRRC75A | Leucine rich repeat containing 75A | Predicted intracellular proteins
| | | | | Tissue enhanced |
MARVELD3 | MARVEL domain containing 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MNX1 | Motor neuron and pancreas homeobox 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MT1HL1 | Metallothionein 1H-like 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MUC3A | Mucin 3A, cell surface associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYO7B | Myosin VIIB | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
NAGS | N-acetylglutamate synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NEUROG3 | Neurogenin 3 | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OLFM4 | Olfactomedin 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
OMP | Olfactory marker protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
P2RY4 | Pyrimidinergic receptor P2Y, G-protein coupled, 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PDZD3 | PDZ domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PDZD7 | PDZ domain containing 7 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PHGR1 | Proline/histidine/glycine-rich 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLA2G2A | Phospholipase A2, group IIA (platelets, synovial fluid) | Enzymes FDA approved drug targets Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLEKHG6 | Pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PLEKHS1 | Pleckstrin homology domain containing, family S member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLS1 | Plastin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |